Brokerages forecast that Castlight Health Inc (NYSE:CSLT) will post sales of $36.02 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Castlight Health’s earnings, with the lowest sales estimate coming in at $36.00 million and the highest estimate coming in at $36.03 million. Castlight Health reported sales of $27.75 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 29.8%. The firm is scheduled to report its next earnings results on Wednesday, April 25th.
According to Zacks, analysts expect that Castlight Health will report full year sales of $36.02 million for the current financial year, with estimates ranging from $152.40 million to $153.67 million. For the next fiscal year, analysts forecast that the company will report sales of $179.05 million per share, with estimates ranging from $175.00 million to $183.54 million. Zacks’ sales averages are an average based on a survey of analysts that follow Castlight Health.
Castlight Health (NYSE:CSLT) last issued its quarterly earnings results on Wednesday, February 21st. The software maker reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.05) by $0.01. Castlight Health had a negative return on equity of 28.76% and a negative net margin of 42.28%. The firm had revenue of $37.00 million during the quarter, compared to analysts’ expectations of $36.36 million. During the same period in the previous year, the business earned ($0.01) earnings per share. The firm’s revenue for the quarter was up 23.7% on a year-over-year basis.
Castlight Health (NYSE CSLT) traded down $0.15 during midday trading on Friday, reaching $3.70. The company’s stock had a trading volume of 388,725 shares, compared to its average volume of 331,856. The firm has a market capitalization of $514.04, a price-to-earnings ratio of -8.22 and a beta of 1.49. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.06 and a quick ratio of 2.06. Castlight Health has a one year low of $3.10 and a one year high of $4.75.
In other news, CFO Mangini Siobhan Nolan sold 18,201 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total value of $66,069.63. Following the transaction, the chief financial officer now owns 120,788 shares of the company’s stock, valued at approximately $438,460.44. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO John C. Doyle sold 10,644 shares of the company’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $3.63, for a total value of $38,637.72. Following the completion of the transaction, the chief executive officer now directly owns 157,422 shares in the company, valued at approximately $571,441.86. The disclosure for this sale can be found here. Insiders have sold 33,184 shares of company stock worth $120,762 in the last three months. 24.38% of the stock is currently owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Castlight Health by 36.0% in the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock valued at $15,094,000 after purchasing an additional 963,188 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Castlight Health by 1.3% in the 4th quarter. BlackRock Inc. now owns 3,575,033 shares of the software maker’s stock valued at $13,406,000 after buying an additional 44,923 shares during the period. Gagnon Securities LLC raised its holdings in shares of Castlight Health by 3.3% in the 3rd quarter. Gagnon Securities LLC now owns 1,484,726 shares of the software maker’s stock valued at $6,384,000 after buying an additional 47,398 shares during the period. Cowen Prime Services LLC raised its holdings in shares of Castlight Health by 727.5% in the 4th quarter. Cowen Prime Services LLC now owns 1,353,106 shares of the software maker’s stock valued at $5,074,000 after buying an additional 1,189,586 shares during the period. Finally, State Street Corp raised its holdings in shares of Castlight Health by 48.1% in the 2nd quarter. State Street Corp now owns 973,648 shares of the software maker’s stock valued at $4,037,000 after buying an additional 316,319 shares during the period. 43.80% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Castlight Health Inc (CSLT) Expected to Post Quarterly Sales of $36.02 Million” was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://stocknewstimes.com/2018/03/20/castlight-health-inc-cslt-expected-to-post-quarterly-sales-of-36-02-million.html.
Castlight Health Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.